StonvexLoading…
StonvexStonvexStonvexCore line items from INGR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $7.22B | $1.82B | $1.83B | $1.81B |
Operating Income | $1.02B | Not available | Not available | Not available |
Net Income | $729.00M | $171.00M | $196.00M | $197.00M |
EPS (Diluted) | $11.18 | $2.61 | $2.99 | $3.00 |
Total Assets | $7.90B | Not available | Not available | Not available |
Total Liabilities | $3.53B | Not available | Not available | Not available |
Cash & Equivalents | $1.03B | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | $511.00M | Not available | Not available | Not available |
Shares Outstanding | 65.20M | Not available | Not available | Not available |